header image header image
About Dogs 3D Joints

About Us

This platform has been developed by Boehringer Ingelheim to support veterinarians in visualising and explaining the most common joint pathologies in dogs to pet owners, veterinary students and animal healthcare practitioners.

Dogs 3D Joints is fully equipped with the most innovative 3D technology and allows veterinarians to interactively demonstrate the pet’s joint structures and functions, both in healthy and diseased joints. This virtual simulation of high-resolution anatomical 3D models provides assistance to support communication and education of canine joint diseases.


The 3D models allow for interaction with the dog’s joints by flexing, extending, rotating 360-degrees and zooming into high-definition images for a detailed view. Anatomical structures and pathologies can be added or removed, so that the relevant area of the joint can be effectively visualised in both healthy and unhealthy states.

dog_&_owner

What can you find in Dog 3D Joints?

1. 3D Joint Simulator / 3D Joints Image Viewer

This is the main section of the website, providing interaction with realistic 360-degree anatomical models of the joints.

2. Documents

This section contains fact sheets summarising the most important information about joint diseases in dogs. These can be downloaded for free.

3d_joints_simulator

Pathologies and anatomical structures

1. Stifle joint

  • Rupture of the cranial cruciate ligament

  • Patellar luxation

2. Hip joint

  • Hip dysplasia

  • Osteochondritis dissecans of the Shoulder

3. Elbow joint

  • Fragmented coronoid process

  • Ununited anconeal process

  • Osteochondritis dissecans

4. Shoulder joint

  • Osteochondritis dissecans of the humeral head

  • Luxation

two_dogs_examples

About the developers

Dogs 3D Joints has been developed exclusively by Grupo Asis for Boehringer Ingelheim with the support of the Jesús Usón Minimally Invasive Surgery Centre (JUMISC).

Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies. Headquartered in Ingelheim, Germany, the company operates globally with approximately 52,000 employees. Since its founding in 1885, the company has remained family-owned and today creates value through innovation for three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.

JUMISC is a multidisciplinary institution, located in Cáceres, Spain, that is devoted to research and innovation in human and veterinary health sciences. Their aim is to improve the quality of healthcare delivered to patients, by providing surgeons and other health professionals with innovative solutions and training.